First-in-human study to assess guselkumab (anti-IL-23 mAb)...

European Journal of Clinical Pharmacology 2016 / 11 Vol. 72; Iss. 11

First-in-human study to assess guselkumab (anti-IL-23 mAb) pharmacokinetics/safety in healthy subjects and patients with moderate-to-severe psoriasis

Zhuang, Yanli, Calderon, Cesar, Marciniak, Stanley J, Bouman-Thio, Esther, Szapary, Philippe, Yang, Tong-Yuan, Schantz, Allen, Davis, Hugh M., Zhou, Honghui, Xu, Zhenhua
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Volume:
72
Language:
english
Journal:
European Journal of Clinical Pharmacology
DOI:
10.1007/s00228-016-2110-5
Date:
November, 2016
File:
PDF, 379 KB
english, 2016
Conversion to is in progress
Conversion to is failed